We are live on ! Find out more
ARWR icon

Arrowhead Research

277 hedge funds and large institutions have $2.35B invested in Arrowhead Research in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 97 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $19.4M | Put options by funds: $15.2M

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

0% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 97

0% less funds holding

Funds holding: 278277 (-1)

1.16% less ownership

Funds ownership: 68.31%67.15% (-1.2%)

8% less capital invested

Capital invested by funds: $2.54B → $2.35B (-$197M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
277
Holders Change
-1
Holders Change %
-0.36%
% of All Funds
4.75%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
28
Increased
97
Reduced
97
Closed
26
Calls
$19.4M
Puts
$15.2M
Net Calls
+$4.19M
Net Calls Change
+$3.82M

ARWR Hedge Fund Activity: Q3 2022 in Review

277 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q3 2022, worth a combined $2.35B — down 7.7% from $2.54B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ARWR positions and 26 closed out — a net gain of 2 holders — while 97 added to existing stakes and 97 trimmed.

The largest buyer was Rokos Capital Management (UK), opening a new position worth an estimated $16.2M. The largest seller was Johnson & Johnson, cutting an estimated $40.9M.

  • 277 institutional investors held Arrowhead Research (ARWR) as of Q3 2022, down from 278 in Q2 2022.
  • Funds reported $2.35B of Arrowhead Research stock for Q3 2022, down 7.7% quarter-over-quarter.
  • 28 funds opened new Arrowhead Research positions in Q3 2022 and 26 closed out, a net change of +2 holders.
  • The largest Arrowhead Research buyer in Q3 2022 was Rokos Capital Management (UK), an estimated $16.2M added.
  • The largest Arrowhead Research seller in Q3 2022 was Johnson & Johnson, an estimated $40.9M sold.

Based on aggregated 13F filings for Q3 2022.